Keio Innovation Initiative

LIFESCAPES is a researcher and manufacturer of brain-computer interface equipment. LIFESCAPES aims to use BMI technology to help stroke patients solve problems and improve their quality of life. LIFESCAPES uses BMI to bring out the plasticity of the brain and help people who are in trouble to be free of their limitations and to live their lives normally.

K-Pharma creates pharmaceuticals by utilizing early-stage neuro regenerative medicine and iPS drug discovery. They also research, manufacture, and develop medical products and pharmaceuticals.

FingerVision consists of specialists in this field to generate robot motions. The company solves social issues by putting advanced visual and haptic technology from universities into practice and expanding the application areas of robots and machines.

Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.

Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.

Luxonus is a medical device manufacturing company that offers new imaging device with optical ultrasonic technology.

Grace Imaging is a development of advanced fatigue measurement service by lactic acid sensing in sweat and MRI technologies.

Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.

Metagen Therapeutics is a drug discovery and medical business company which utilizes microbiome science. The company promotes drug discovery and medical business using microbiome science. Metagen Therapeutics is a joint venture between Fast Track Initiative Co., Ltd. and Keio Innovation Co., Ltd.

B dot Medical creates ultra-compact proton beam cancer therapy equipment. B dot Medical provides scanning irradiation, magnet design, gantry, and treatment couch features. B dot Medica creates an ultra-compact proton therapy system that defies conventional cancer treatment wisdom.

Connect Japan is developing services that connect people.

AdipoSeeds, though a novel technology, creates platelets from mesenchymal stem cells without a complex and costly gene transfer. It aims to invent new blood supply system to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided.

Founded in 2020, Skygate Technologies is building a network to deliver a large volume of data from observation satellites around the Earth to the ground and integrating the network into the web architecture. “Make Space accessible on the Web” is its motto, and the ability to develop both hardware and software is its strength. More information about Skygate Technologies can be found at www.skygate-tech.com.

Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.

Bonx provides wearable outdoor sports group-talk technology. Bonx creates and develops Bonx Grip, a water and shock proof unit that enables group conversations between outdoor athletes.

APB specializes in the research, development, manufacturing, and sales of lithium-ion batteries. They use polymer instead of metal for current collectors and active materials are coated with dedicated polymer materials. They offer lithium-ion batteries and all-polymer batteries for consumer, automotive, and large-scale energy storage solutions. It utilizes a polymer resin and a bipolar structure that enables the high energy density of the batteries.

Kringle Pharma, Inc. is a biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF) protein medicines and NK4 molecules. Established in 2001 and headquartered in Japan, the company aims to harness the regenerative properties of HGF for various medical conditions, including acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scarring. In addition to HGF, Kringle Pharma develops NK4, which acts as an antagonist to HGF and exhibits anti-cancer properties by inhibiting tumor cell invasion and metastasis. The company's product pipeline includes recombinant human HGF for treating acute renal failure, skin ulcers, and central nervous system disorders, as well as NK4 and NK4 gene therapies for cancer treatment.

Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.

Luxonus is a medical device manufacturing company that offers new imaging device with optical ultrasonic technology.

Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure human activity over a wide area on earth, regardless of time or weather.

Motion Lib is a developer of haptics technology intended to increase collaboration between humans and robots.The company develops a chip that estimates and calculates the repulsive force (feel) of what is being touched from the load force applied to the motor for robots, increasing the number of places where machines can play an active role and increasing the productivity of society as a whole.

Instalimb is the world's first 3D printing prosthesis business.

xenodata lab., In the mission "Technology proposal suggests naturally after five years", in order to make the shape of the future financial industry with novel technology, ideas February 2016 It was founded in. xenodata is a coined word that spells the idea of ​​creating heterogeneous creatures according to data, and by means of the intelligence created by the data, the meaning to pursue the substitution of human actions to the utmost is put in the meaning.

Luxonus is a medical device manufacturing company that offers new imaging device with optical ultrasonic technology.

Himuka AM Pharma is a pharmaceutical company focusing on the development of Adrenomedullin derivatives. Himuka AM Pharma creates drug candidates based on the bioactive peptide adrenomedullin (AM), which was discovered at the University of Miyazaki (formerly Miyazaki Medical College). Their drug candidates will make significant contributions to the resolution of unmet medical needs.

Bonx provides wearable outdoor sports group-talk technology. Bonx creates and develops Bonx Grip, a water and shock proof unit that enables group conversations between outdoor athletes.

CureApp is a digital health startup.The firm is one of the leading players in the medical app vertical under the theme of “app exhibits therapeutic effects against diseases” and launched a nicotine addiction treatment app in February 2015, which was jointly developed with Division of Pulmonary Medicine, Keio University’s School of Medicine. It is currently conducting clinical trials in many locations.

Tsubota Laboratory engages in research and development related to the prevention and treatment of myopia, dry eye, presbyopia, other eye diseases, and systemic diseases. They develop evidence-based solutions.

Institution for a Global Society provides education institutions and businesses with innovative, seamless, and bias-less assessment solutions. The company's solutions include GROW Academy, DxGROW, Ai GROW, and GROW360. The company uses appropriate technology ethically to create a society where everyone can sustainably learn and develop over the course of a lifetime.

IDAC Theranostics is a Biotechnology Company and drug creation and R & D for diseases that only require coping therapy.

Motion Lib is a developer of haptics technology intended to increase collaboration between humans and robots.The company develops a chip that estimates and calculates the repulsive force (feel) of what is being touched from the load force applied to the motor for robots, increasing the number of places where machines can play an active role and increasing the productivity of society as a whole.

Generic Solution offers GS8 software for information retrieval and machine learning. The company also provides distributed computing services, data model design, and data analysis. Generic Solution's goal is to give its customers measurable outcomes through the company's generic solutions products to increase its competitiveness in the market.

Bonx provides wearable outdoor sports group-talk technology. Bonx creates and develops Bonx Grip, a water and shock proof unit that enables group conversations between outdoor athletes.

CureApp is a digital health startup.The firm is one of the leading players in the medical app vertical under the theme of “app exhibits therapeutic effects against diseases” and launched a nicotine addiction treatment app in February 2015, which was jointly developed with Division of Pulmonary Medicine, Keio University’s School of Medicine. It is currently conducting clinical trials in many locations.

Quan Inc. develops characters and game content to smartphone platforms and offers global content distribution services. It offers more than 500 characters in the form of stamp and illustrations to national and international chat apps and smartphone platforms; creates content for social games and casual games, keyboard apps, stamp applications such as deco-based applications, and more; and performs PR and advertising services in the fields of market research and analysis, translation, specification changes, and game management. Quan Inc. was founded in 2011 and is based in Tokyo, Japan.

AdipoSeeds, though a novel technology, creates platelets from mesenchymal stem cells without a complex and costly gene transfer. It aims to invent new blood supply system to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided.

Kringle Pharma, Inc. is a biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF) protein medicines and NK4 molecules. Established in 2001 and headquartered in Japan, the company aims to harness the regenerative properties of HGF for various medical conditions, including acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scarring. In addition to HGF, Kringle Pharma develops NK4, which acts as an antagonist to HGF and exhibits anti-cancer properties by inhibiting tumor cell invasion and metastasis. The company's product pipeline includes recombinant human HGF for treating acute renal failure, skin ulcers, and central nervous system disorders, as well as NK4 and NK4 gene therapies for cancer treatment.

SENSY is personal artificial intelligence that understands people's senses. By having one artificial intelligence, SENSY learns the "sensitivity" of each user and creates a life-changing encounter with various lifestyles.